Assistant Professor of Medicine
Dana-Farber Cancer Institute, Harvard Medical School
Boston, Massachusetts
Caron A. Jacobson, MD, MMSc, is an oncolgist who specializes in lymphoma at the Dana-Farber Cancer Institute. She does clinical and translational research in lymphoma and in CAR T-cell therapy and is the medical director of the Immune Effector Cell Therapy Program at DFCI, which oversees both the commercial CAR T-cell programs in lymphoma and leukemia, as well as the research programs in all engineered cell therapies, which span multiple different disease centers.
Disclosure information not submitted.
Wednesday, March 23, 2022
8:40 AM – 10:35 AM
Wednesday, March 23, 2022
9:05 AM – 9:25 AM
Wednesday, March 23, 2022
9:25 AM – 9:40 AM
Wednesday, March 23, 2022
10:35 AM – 10:55 AM
Thursday, June 23, 2022
8:30 AM – 10:25 AM
Thursday, June 23, 2022
8:55 AM – 9:15 AM
Thursday, June 23, 2022
10:05 AM – 10:25 AM
Thursday, June 23, 2022
3:50 PM – 5:15 PM
Thursday, June 23, 2022
4:15 PM – 4:35 PM
Thursday, June 23, 2022
4:55 PM – 5:15 PM